The results of the binary logistic regression analysis indicated that ECV, CRP, IL-6, and NEU were influencing factors for the efficacy of ICIs in patients with liver cancer (P < 0.05), as shown in Tables 2, 3. This evidence concerns the gene IL6 and liver cancer.